PTIE: Summary for Pain Therapeutics - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:01pm SGT - The Singapore stock market is closed.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

Pain Therapeutics Inc. (PTIE)

At 5:00AM SGT: 5.56 USD 0.00 (0.00%)

MORE ON PTIE

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Pain Therapeutics (NasdaqNM:PTIE) Delayed quote data

Last Trade:	5.56 USD
Trade Time:	5:00AM SGT
Change:	0.00 (0.00%)
Prev Close:	5.56
Open:	N/A
Bid:	5.15 x 400
Ask:	5.90 x 1800
1y Target Est:	5.00

Day's Range:	N/A - N/A
52wk Range:	3.20 - 6.26
Volume:	0
Avg Vol (3m):	207,941
Market Cap:	235.18M
P/E (ttm):	N/A
EPS (ttm):	-0.11
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Use Y! Toolbar to track stocks

Add PTIE to Portfolio

Download Data

HEADLINES

•	PAIN THERAPEUTICS INC Financials
	EDGAR Online Financials (Sat, Feb 6)

•	PAIN THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rights
	EDGAR Online (Wed, Feb 3)

•	PAIN THERAPEUTICS INC Files SEC form 10-K, Annual Report
	EDGAR Online (Tue, Feb 2)

•	New Star Analyst Rankings for Pain Therapeutics
	StarMine (Sat, Jan 30)

•	PAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Thu, Jan 28)

•	Pain Therapeutics Announces 2009 Financial Results, Outlines Business Priorities
	GlobeNewswire (Thu, Jan 28)

•	PAIN THERAPEUTICS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Material Modification to Ri
	EDGAR Online (Wed, Jan 27)

•	PAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Fri, Jan 8)

•	5 Stocks Bouncing Back
	at Motley Fool (Sat, Dec 12)

•	Today's 5-Star Movers
	at Motley Fool (Sat, Dec 5)

More Headlines for PTIE...

ANALYST

EPS Est (next year) (Dec-09) :	-0.11
EPS Est (in 2 years) (Dec-10) :	-0.26
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of novel drugs. It has four drug candidates in clinical development programs, which include Remoxy, a novel controlled-release oral capsule form of oxyco...

Full Company Profile

Add to Portfolio

Email to a Friend

•